NCT00335894View on ClinicalTrials.gov

Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF).

PHASE3CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

March 31, 2009

Conditions
Infertility
Interventions
DRUG

hMG-IBSA

Trial Locations (2)

40138

Università degli Studi di Bologna, Bologna

80131

Università degli Studi di Napoli Federico II, Napoli

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT00335894 - Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF). | Biotech Hunter | Biotech Hunter